Respiratory Pharmacology Flashcards
Diphenhydramine
- 1st generation H1 blocker
- Reversible inhibitor of H1 histamine receptor
- Uses:
- allergy
- Motion sickness
- Sleep aid
- Toxicity:
- Sedation
- Antimuscarinic
- Anti-alha-adrenergic
Dimenhydrinate
1st generation H1 blocker
- Reversible inhibitor of H1 histamine receptor
- Uses:
- allergy
- Motion sickness
- Sleep aid
- Toxicity:
- Sedation
- Antimuscarinic
- Anti-alha-adrenergic
Chlorpheniramine
1st generation H1 blocker
- Reversible inhibitor of H1 histamine receptor
- Uses:
- allergy
- Motion sickness
- Sleep aid
- Toxicity:
- Sedation
- Antimuscarinic
- Anti-alha-adrenergic
Loratadine
- 2nd generation H1 blocker
- Reversible inhibitor of H1 histamine receptors
- Uses: allergy
- Toxicity: less sedation than 1st generation b/c less into CNS
Fexofenadine
- 2nd generation H1 blocker
- Reversible inhibitor of H1 histamine receptors
- Uses: allergy
- Toxicity: less sedation than 1st generation b/c less into CNS
Desloratadine
- 2nd generation H1 blocker
- Reversible inhibitor of H1 histamine receptors
- Uses: allergy
- Toxicity: less sedation than 1st generation b/c less into CNS
Certirizine
- 2nd generation H1 blocker
- Reversible inhibitor of H1 histamine receptors
- Uses: allergy
- Toxicity: less sedation than 1st generation b/c less into CNS
Isoproterenol
- Non specific beta agonist
- Treat asthma
- relaxes bronchial smooth muscle (beta 2)
- Adverse effect: tachycardia via beta 1
Albuterol
- Beta 2 agonist
- treat asthma
- Relaxes bronchial smooth muscle via beta 2
- Use during acute exacerbation
Salmeterol
- Beta 2 agonist
- Treat asthma
- long acting agent for prophylaxis
- ≥12 hour duration (versus 1-4 hours) (great for nocturnal asthma attacks)
- long duration due to high lipid solubility
- Adverse effects: tremor & arrhythmia
Theophylline
- Methylaxamine (also includes caffeine and theobromine)
- Treats Asthma
- Bronchodilation by inhibiting phosphodiesterase
- Decreases cAMP hydrolysis
- Limited use due to narrow therapeutic index
- Cardiotoxicity and neurotoxicity
- Caffeine like symptoms
- Metabolized by P-450
- Blocks action of adenosine
Ipratropium
- Competitive block of muscarinic receptors
- Same as atopine
- Also, tiotropium long acting
- Treats asthma
- Prevents bronchoconstriction
- Also used for COPD
Cromolyn
- Prevents release of mediators from mast cells
- Effective only for prophylaxis of asthma
- Not effective during acute asthma attack
- Toxicity is rare
Prednisone
- Corticosteroid
- beclomethasone, fluticasone, budesonide inhaled
- Inhibits synthesis of all cytokines
- Inactivates NF-kappa B
- NF-kappa B: transcription factor inducing TNF alpha
- 1st line therapy for chronic asthma
Zileuton
- Antileukotrienes
- 5 lipoxygenase pathway inhibitor
- Blocks conversion of arachidonic acid to leukotrienes
Zafirlukast & Montelukast
- Block leukotriene receptors
- Especially good for aspirin induced asthma
Epinephrine
- Non selective beta agonist
- relaxes bronchial smooth muscle via B2 activation
- effective & rapidly acting when given s.c. or inhaled as an aerosol
- side-effects:
- tachycardia, arrhythmias, aggravated angina
terbutaline
Short Acting β2 Agonists
• inhaled or oral
• albuterol, terbutaline, metaproterenol, and
bitolterol are equivalent to isoproterenol (in
terms of bronchodilation) when given by
inhalation
• only terbutaline is available s.c. (emergency
therapy)
Omalizumab
-Recombinant humanized IgG1 monoclonal anti-IgE antibody
• Binds IgE preventing interaction w/mast cells
-blocks IgE-dependent mast cell activation.
-Binds Fc region.
-Useful for patients with persistent asthma
-Particularly w/ evidence of a sensitization to allergens
Side effects:
-increased upper respiratory infections
-headache
-Possible slight increase in incidence of cancer
Drugs for COPD:
-Bronchodilators:
-Short acting beta-2 agonists: albuterol
-Long acting beta-2 agonists: salmeterol
-Short acting anticholinergics: ipratropium bromide
-Long acting anticholinergics: tiotropium bromide
-In COPD patients, the use of anticholinergics is associated
with increased risk of cardiovascular events (MI)
-Prophylactic antibiotic: Chronic azithromycin (hearing loss)